probenecid

Probenecid (Benemid) is a benzoic acid derivative with antihyperuricemic property.

Probenecid sodium is the sodium salt of Probenecid, a potent and selective agonist of transient receptor potential vanilloid 2 (TRPV2) channels. Additionally, Probenecid acts as an inhibitor of pannexin 1 channels.

Probenecid-D14 (4[(Dipropylamino-d14)sulfonyl]benzoic Acid) is a deuterium-labeled isotope of Probenecid (T0457) and can be used for isotope tracing. Probenecid, a benzoic acid derivative, exhibits antihyperuricemic properties and selectively activates the transient receptor potential vanilloid receptor 2 (TRPV2) while also inhibiting the pannexin 1 channel.

Probenecid (Standard) is the standard form of Probenecid, suitable for quantitative analysis, quality control, biochemical experiments, and related research. Probenecid is a benzoic acid derivative with anti-hyperuricemic properties. It selectively activates the transient receptor potential vanilloid receptor channel 2 (TRPV2) and also inhibits the pannexin 1 channel.

Probenecid acyl β-D-glucuronide is a biochemical reagent utilized in glycobiology research. The study of glycobiology focuses on the structure, synthesis, biology, and evolution of sugars. This field encompasses carbohydrate chemistry, the enzymology of glycan formation and degradation, protein-glycan recognition, and the role of glycans in biological systems. It is closely linked to fundamental research, biomedicine, and biotechnology.

Anticanceragent 191 (Compound 2) is a probenecid derivative. It functions as an efflux inhibitor targeting cancer cells by inhibiting P-glycoprotein (P-gp), breast cancer resistance protein (BCRP), and/or multiple multidrug resistance proteins (MRPs). Anticanceragent 191 enhances the accumulation of vincristine within cancer cells and is utilized for cancer research.